HOME >> MEDICINE >> NEWS
Statement on the findings of the Women's Health Study

The Women's Health Study is the first large clinical trial to study the use of low-dose aspirin to prevent heart attack and stroke in women. The 10-year randomized, double-blind, placebo-controlled study was conducted among nearly 40,000 healthy women age 45 and older. Although studies have shown that low-dose aspirin reduces the risk of a first heart attack in men, there have been few such studies in women. The study was supported by the National Institutes of Health's National Heart, Lung, and Blood Institute and the National Cancer Institute.

The Women's Health Study found that aspirin did not prevent first heart attacks or death from cardiovascular causes in women. Low-dose aspirin (100 mg on alternate days) lowered the incidence of a first major cardiovascular event (nonfatal heart attack, non-fatal stroke, or death from cardiovascular causes) by 9 percent. This was not statistically significant. Stroke was 17 percent lower in the aspirin group, a statistically significant difference. The findings of the study will be presented at the American College of Cardiology's (ACC) annual meeting in Orlando, FL and also published online in The New England Journal of Medicine March 7, 2005 and in print in the March 31 issue.

The greatest benefit appeared to be in women 65 and older. In this sub-group, low-dose aspirin reduced the risk of major cardiovascular events by 26 percent. However, the benefits of low-dose aspirin therapy must be weighed against the risk of an increased chance of internal bleeding, a well-known side effect of aspirin use.

The bottom line is that many women, especially those 65 and older, may benefit from taking low-dose aspirin every other day to prevent stroke. But it is important for women to weigh the risk and benefits of taking aspirin and to consult with their doctor.

Above all, women, like men, should adopt the well-proven approaches that reduce the risk of heart disease eating for heart health,
'"/>

Contact: NHBLI Communications Office
nhlbi_news@nhlbi.nih.gov
301 496-4236
NIH/National Heart, Lung, and Blood Institute
7-Mar-2005


Page: 1 2

Related medicine news :

1. Statement: Implantable medical identification chip
2. Statement from Barbara Alving of NHLBI on guidelines for cardiovascular disease prevention in women
3. Statement from Spondylitis Association of America
4. Statement by Dr. Colwell on Nobel Prizes in Science and NSF onnection
5. The CARDIA Study: Statement from Dr. Claude Lenfant, director, National Heart, Lung, and Blood Institute
6. Statement from Dr. Claude Lenfant, director, NHLBI and Dr. Phillip Gorden, director, NIDDK
7. Statement from Claude Lenfant, M.D., NHLBI Director, on Trends in Hypertension
8. Dental Researchers Retract Statement Indicating Hydrogen Peroxide May Be Cancer Promoter
9. Latest findings on genetic blood disorder Cooleys Anemia
10. Hard choices: Pitt researcher presents findings on when to accept organ transplants
11. Contrary to previous findings, smoking is detrimental to patients with Alzheimers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/14/2019)... ... September 14, 2019 , ... GreenTheVoteOk , one of the ... again tried to bring the most relevant and important developments in the fast-changing world ... increasingly large number of people across the world suffering from different difficult-to-treat ailments, people ...
(Date:9/11/2019)... Pa. (PRWEB) , ... September 12, 2019 , ... “Heart ... living with diagnosed coronary artery disease as he hopes to prevent anyone from having ... creation of published author John Saltwick, a writer who was diagnosed with coronary artery ...
(Date:9/11/2019)... ... 11, 2019 , ... A September 2 article on CBS News ... significantly less likely to suffer heart attacks, strokes, kidney failure, and heart disease versus ... weight loss surgery specialists Dr. Feiz and Associates says the study adds further evidence ...
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... ... will be held September 11-14 in Minneapolis at the Mall of America Radisson ... LaPrade, will be faculty members for the high-profile, knee-focused conference, which brings together ...
(Date:9/11/2019)... DANBURY, Conn. (PRWEB) , ... September 11, 2019 , ... ... helps couples and individuals grow their family, will host a free informational event that ... and a food truck meal voucher for the first fifty registrants. The event, “What’s ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... BOSTON (PRWEB) , ... September 13, 2019 , ... ... provider of teledentistry services for employers, became the first commercial teledentistry practice in ... an award-winning startup with other hub entrepreneurs, company leaders, innovators and industry experts ...
(Date:9/14/2019)... ... ... The Allergenic Products Advisory Committee of the Food and Drug Administration (FDA) ... approval of a standardized oral immunotherapy (OIT) product for peanut allergy. The brand name ... The FDA would require a Risk Evaluation and Mitigation Strategy (REMS) to be developed ...
(Date:9/12/2019)... ... ... Stratosphere Networks will sponsor GRIN2B Foundation’s first cocktail reception fundraiser, Gather ... Kitchen and Social House in Evanston from 6 p.m. to 9 p.m. , Proceeds ... gene on the short arm of the 12th chromosome and is part of a ...
Breaking Medicine Technology:
Cached News: